Publications by authors named "Anja Liepert"

Claim this Profile
I
In Vitro Generated Dendritic Cells of Leukemic Origin Predict Response to Allogeneic Stem Cell Transplantation in Patients With AML and MDS.
Markus Freudenreich, Johanna Tischer, Tanja Kroell, Andreas Kremser, Julia Dreyßig, Anja Liepert

J Immunother· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine Release Patterns in Mixed Lymphocyte Culture (MLC) of T-Cells with Dendritic Cells (DC) Generated from AML Blasts Contribute to Predict anti-Leukaemic T-Cell Reactions and Patients' Response to Immunotherapy.
Dorothea Fischbacher, Marion Merle, Anja Liepert, Christine Grabrucker, Tanja Kroell

Cell Commun Adhes· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4(+)and CD8(+)T-cell reactions against leukemia-associated- or minor-histocompatibility-antigens in AML-patients after allogeneic SCT.
Brigitte Steger, Slavoljub Milosevic, Georg Doessinger, Susanne Reuther, Anja Liepert

Immunobiology· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotyping.
Susanne Reuther, Helga Schmetzer, Friedhelm R Schuster, Pina Krell, Christine Grabrucker, Anja Liepert

Clin Exp Med· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Various 'dendritic cell antigens' are already expressed on uncultured blasts in acute myeloid leukemia and myelodysplastic syndromes.
Julia Dreyssig, Andreas Kremser, Anja Liepert, Christine Grabrucker, Markus Freudenreich

Immunotherapy· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of T-cells after stimulation with leukemia-derived dendritic cells (DC) from patients with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) is predictive for their leukemia cytotoxic potential.
Anja Liepert, Christine Grabrucker, Andreas Kremser, Julia Dreyssig, Christian Ansprenger

Cell Immunol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cells (DCs) can be successfully generated from leukemic blasts in individual patients with AML or MDS: an evaluation of different methods.
Andreas Kremser, Julia Dressig, Christine Grabrucker, Anja Liepert, Tanja Kroell

J Immunother· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
Christine Grabrucker, Anja Liepert, Julia Dreyig, Andreas Kremser, Tanja Kroell

J Immunother· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of soluble and cell-surface expressed 4-1BB ligand in patients with malignant hemopoietic disorders.
Nina Scholl, Julia Loibl, Andreas Kremser, Anja Liepert, Christine Grabrucker

Leuk Lymphoma· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved effector function of leukemia-specific T-lymphocyte clones trained with AML-derived dendritic cells.
Friedhelm R Schuster, Raymund Buhmann, Susanne Reuther, Bernd Hubner, Christine Grabrucker, Anja Liepert

Cancer Genomics Proteomics· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis